arrow
G

Giampaolo Tortora

catholic university of the sacred heart
H指数:93
被引数:6.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Germline pathogenic variants identification through comprehensive cancer genome profiling

通过全面癌症基因组分析鉴定生殖系致病性变异

2026-10-270
OAAI
Interobserver Agreement and Radiological–Pathological Concordance of CT Staging in localized Colon Cancer

不同观察者间对局部结肠癌CT分期的观察者一致性及影像学-病理学一致性

2026-09-010
OAAI
Managing paraneoplastic GABABR-related limbic encephalitis in a patient with a small cell lung cancer receiving an Immune-Checkpoint Inhibitor (ICI) therapy: description of a case report

管理一名接受免疫检查点抑制剂(ICI)治疗的小细胞肺癌患者伴发的副肿瘤性GABABR相关边缘性脑炎:病例报告描述

2025-11-140
OAAI
PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance

PI3K/mTORC2-RICTOR轴在早期鳞状非小细胞肺癌中的研究:基因组学、分子表达及其临床相关性

2025-11-070
OA
Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy

微卫星稳定型结直肠癌中高肿瘤突变负荷的基因组分析揭示了抗-EGFR治疗后MAPK信号通路的改变

2025-10-280
OAAI
Immunohistochemical expression of Ki-67, INSM1, and SSTR2A in medullary thyroid carcinoma: correlation with tumour size, vascular invasion, and biochemical outcome

髓样甲状腺癌中Ki-67、INSM1和SSTR2A的免疫组织化学表达:与肿瘤大小、血管侵犯及生化结局的相关性

2025-10-250
OA
Prognostic impact of Geriatric 8 and comprehensive geriatric assessment in older patients with advanced pancreatic ductal adenocarcinoma

老年评估量表(Geriatric 8)和综合老年评估在晚期胰腺导管腺癌老年患者中的预后影响

2025-10-180
OAAI
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer

ctDNA指导下的辅助阿特珠单抗治疗在肌肉浸润性膀胱癌中的应用

2025-10-0110
PRE
Network analysis of NRG1 variants of uncertain significance (VUSes) in advanced non-small-cell lung cancer and their prognostic role in EGFR-mutant patients treated with first-line osimertinib

NRG1变异体不确定意义(VUSes)在晚期非小细胞肺癌中的网络分析及其在EGFR突变患者接受一线奥希替尼治疗中的预后作用

2025-08-290
OAAI
Effectiveness of nivolumab-based immunotherapy and prognostic stratification by the Meet-URO score in real-world older patients with metastatic renal cell carcinoma

基于纳武利尤单抗的免疫疗法在真实世界老年转移性肾细胞癌患者中的疗效及通过Meet-URO评分进行的预后分层

2025-08-120
PRE
Contemporary Analysis of Cardiac Tamponade Etiologies, Treatments, and Outcomes: The CATEO Study

当代心包填塞病因、治疗及预后分析:CATEO 研究

2025-08-010
PRE
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study)

ASTEROID研究:辅助De Gramont方案与Xelox化疗在切除胃癌中的真实世界疗效比较:一项倾向性评分匹配分析

2025-07-260
OAAI
Predictive risk factors of recurrence in breast cancer after neoadjuvant treatment: the NEORISK study

新辅助治疗后乳腺癌复发的预测风险因素:NEORISK研究

2025-06-140
PRE
Upfront Oxaliplatin-Fluoropyrimidine Chemotherapy and Somatostatin Analogues in Advanced Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Tumors

奥沙利铂-氟嘧啶化疗和生长抑素类似物在晚期高分化胃肠胰腺神经内分泌肿瘤中的应用

CANCERS
IF4.4
2025-05-030
OA
The Impact of Uncommon HRR Alterations as Predictors of Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials

罕见同源重组修复(HRR)改变作为转移性去势抵抗性前列腺癌中PARP抑制剂疗效预测因子的影响:一项随机对照试验的荟萃分析

2025-04-170
PRE
Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial

液体活检综合基因组分析描绘了转移性结直肠癌的突变景观,以预测CAPRI-2 GOIM试验中FOLFIRI联合西妥昔单抗的抗肿瘤疗效。

2025-04-010
PRE